Search results
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: American Express,...
Zacks via Yahoo Finance· 2 days agoStocks recently featured in the blog include: American Express Co. AXP, Walmart Inc. WMT, Amazon.com...
The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E
Zacks via Yahoo Finance· 6 days agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Lilly partners with Aktis, deepening radiopharma investment
BioPharma Dive via Yahoo Finance· 1 day agoAnd in 2023, Merck & Co’s venture arm participated in the company’s Series A extension, which raised...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 21 hours agoBeyond 2030, the drugmaker expects to add radiopharmaceuticals, or hybrid radiation-emitting drugs,...
AltruBio lands up to $225M after shift to immune drug research
BioPharma Dive via Yahoo Finance· 1 day agoThe Phase 2a study AltruBio currently has underway in ulcerative colitis should produce results in...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 6 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Lilly's Once-Weekly Insulin Top-Line Results Show Benefit
Medscape· 6 days agoEli Lilly has announced positive phase 3 topline results for its once-weekly insulin efsitora alfa...
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
Digital Journal· 4 hours agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, announced today that it ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 8 hours agoGlobal Antibiotics Market Projected to Reach $49.6 Billion by 2027 PR Newswire BOSTON, May 22, 2024 Global Antibiotics Market, as forecasted by BCC Research, to Grow at a Compound Annual Growth Rate (CAGR) of 4.2% Through 2027 BOSTON, May 22, 2024
Forbion-backed biotech Progentos debuts with $65M for MS drug
BioPharma Dive via Yahoo Finance· 2 days agoProgentos says the money will go toward expanding its pipeline and pushing an experimental treatment...
